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Leukemia currently accounts for some 10 percent ofcancers, and maintains an even
greater position in terms of its human impact because it so frequently strikes children
and young people. Though the leukemias have been incurable until quite recently,
enormous advances have been made in the understanding oftheir basic biology and in
medical intervention. In addition, they occupy an essential role as a model for research
on oncologic pathogenesis and therapeutic investigations ofhuman cancers. Volume 28
of the continuing UCLA Symposia on Molecular and Cellular Biology is devoted to
reviewing these recent advances in leukemia biology and treatment and to projecting
future research directions in this active field. Editors Robert Gale and David Golde
have arranged the 53 papers from a symposium in January 1985 into seven sections:
oncogenes and chromosomes, viruses, growth factors and receptors, hematopoietic
stem cells, pathogenesis, pharmacology, and therapy ofleukemia.
As in other areas ofoncology, research in leukemia has yielded much progress in the
laboratory, with relatively few recent advances in actual patient treatment. Under-
standably, then, the first three chapters concerning the genetic, viral, and hormonal
aspects of leukemias somewhat overshadow the clinical reports, with the exception of
work on CML, which has proven profitable at both the basic and clinical ends of the
spectrum. Certainly the most intellectually satisfying section of this symposium is the
very first, which provides an excellent summary ofsome ofthe first work definitely to
implicate chromosomal translocations and oncogene products in the pathogenesis of
leukemias and lymphomas. This sampling ofthe significant amount ofevidence which
has accrued over the past five years to implicate the "Philadelphia chromosome" in the
induction of CML includes Robert Gale's work, showing that the specific fused
transcript in this rearrangement results in the production of a modified oncogene-
coded protein bearing tyrosine kinase activity. Other papers in this chapter review the
mechanisms ofgenomic rearrangement in tumor cell lines such as Burkitt's lymphoma
and Wilms' tumor.
Robert Gallo begins the chapter on viral oncology with a timely historical review of
his research on retroviruses, in particular the HTLV-I virus, and the recent renewed
interest in these viruses in the pathogenesis ofdisease. Also included in this section is a
fascinating, if rather scantily supported, hypothesis proposing that EBV-infected B
lymphocytes may serve as a biological reservoir for HTLV-III retrovirus during the
asymptomatic, chronic carrier state in AIDS patients.
The next chapter concerns the physiological control mechanisms that hematopoietic
growth factors employ in regulating cell number and function and focuses on the
ability ofcertain leukemic cell lines to secrete autostimulatory growth factors. Several
papers discuss the idea that certain leukemias may be caused by an abnormal
production of stimulatory growth factors by the proliferating malignant cells them-
selves, thus becoming independent of exogenously produced regulatory factors.
Perhaps what is most exciting about these initial chapters concerning basic research in
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leukemia is not so much the sheervolume ofinformation, but the sense that these three
streams ofthought are gradually finding certain common mechanistic ground wherein
genetics, viruses, and hormones may all play discrete parts in the pathogenesis ofthese
complex disorders. It is toward this goal that editors Gale and Golde vigorously
encourage future research directions in hope of achieving a broader understanding of
these and other cancers.
The second half of this symposium deals with more clinical issues and problems in
the treatment of leukemias. A chapter on pharmacology discusses the molecular
mechanisms of acquired malignant cell drug resistance to specific agents. It includes
Joseph Bertino's work with methotrexate resistance and the experimental antifolate
trimetrexate, as well as several clinical trials of varying drug regimens of cytosine
arabinoside for use as a CNS prophylactic. The final chapter on therapy provides an
excellent summary of the most up-to-date drug regimens, therapeutic tactics, and
prognosis in childhood and adult ALL, AML, CML, CLL, and hairy-cell leukemia.
Particular emphasis is placed on the encouraging advances made in allogeneic bone
marrow transplants and experimental work with autologous marrow treated in vitro
with monoclonal antibodies and complement. As exciting as these successes have been,
Gale appropriately reminds the reader of how limited the patient population with
histocompatible donors is and advocates using our recent fundamental advances in the
understanding ofthe basic biology ofleukemias to lead, it is hoped, to the development
of more effective and less toxic approaches to the treatment ofthese diseases.
This well-balanced symposium avoids the pitfalls to which many volumes ofthis size
succumb, by neither losing focus of the clinical issues nor attempting to address too
large a scientific field. It provides a wide representation of topics in sufficient depth to
be ofinterest to the molecular biologist as well as the student ofresearch oncology and
is more thanjust academic reading for the medical oncologist.
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VIROLOGY IN MEDICINE. Edited by Henry Rothschild and J. Craig Cohen. New York,
Oxford University Press, 1985. 334 pp. $39.95.
The study of virology remains one of the frontiers of medicine. Viruses have been
implicated in a wide range of disease processes in all fields of medicine, from trivial
upper respiratory tract infections to malignancy. It is a sign ofour ignorance, however,
that a viral etiology is often postulated either as a diagnosis ofexclusion-as in cases of
gastroenteritis or upper respiratory tract infections, or as a potential cause of a poorly
understood disease-as in the case ofmultiple sclerosis or Type I diabetes.
Until recently, diagnostic methods have not been readily available, and there was
little in the way ofantiviral therapy to offer even ifa specific diagnosis could be made.
These factors further diminished interest in virology among clinicians.
All of this is changing rapidly. Viruses have been implicated in an ever-growing
number of disease processes, including AIDS. Effective and rapid assays using
immunologic techniques have been mass marketed, and new antiviral agents, such as
acyclovir, have removed viruses from the category ofuntreatable pathogens.
The book is intended as a basic reference for students and clinicians, and covers a
comprehensive range oftopics. Beginning with sections on viral structure and function,